Araceli Biosciences launches Endeavor high content analysis platform

Araceli Biosciences, a provider of advanced biological imaging platforms, announced the launch of its flagship product, the Araceli Endeavor™. Endeavor revolutionizes drug discovery by delivering high speed, high resolution, full well scanning of cell-based assays.

Endeavor images 10 times the biology in a fraction of the time, acquiring every cell, every time. Endeavor combines exceptionally fast, full well imaging with sub-half micron pixel resolution, generating high quality, high-resolution data.

With no training required, the Araceli platform makes high content analysis comprehensive, fast and easy. With intelligent tools users can generate quality results quickly and confidently, reducing the time needed for drug discovery. A single Endeavor system can acquire over 20,000 complete wells per day, at a market-leading rate of 480 megapixels/second.

“The role of high content analysis in drug discovery has unfortunately been limited in the last 20 years due to throughput,” says Jeff Harris, General Manager of Araceli Biosciences. “It just hasn’t been fast enough. We set out to change that.”

“We are very excited to release Endeavor and address a tremendous need in the drug discovery space,” says Maggie Vantangoli Policelli, Ph.D. “For far too long, high content analysis has meant compromise – sacrificing either speed or sample coverage. Now Endeavor collects ultra-high-resolution data of every cell quickly. It is a game-changer – with high-resolution full-well imaging, you can see more biology than ever before, faster than ever before.”

For more of the latest science news, straight to your inbox, become a member of SelectScience for free today>>